(211 days)
Not Found
No
The document describes a mechanical hip implant system and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is intended to replace a hip joint and alleviate severe hip pain and disability due to various conditions, which are therapeutic aims.
No
The MSA Hip System is described as a modular hip replacement system intended for surgical implantation, not for diagnosing medical conditions.
No
The device description clearly states it is a modular hip system consisting of a stem and modular neck made of metal alloys, indicating it is a physical implant, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The provided text describes a surgical implant (a hip replacement system) that is physically placed inside the body.
- Intended Use: The intended use is to replace a hip joint in patients with various hip conditions. This is a surgical procedure, not a diagnostic test performed on a sample outside the body.
The device is a medical device, specifically a prosthetic implant, but it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The MSA Hip System is indicated for cementless use and is intended to replace a hip joint. The device is intended for: skeletally mature individuals undergoing primary surgery for total hip replacement patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fracture of the femur. patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis patients suffering from disability due to previous fusion patients with acute femoral neck fractures.
Product codes (comma separated list FDA assigned to the subject device)
MEH
Device Description
The MSA Hip System is a modular hip system consisting of a short stem which mates with a modular neck. The proximal portion of the stem has a plasma spray coating and a hydroxyapatite coating. The MSA Hip System can be mated with a number of previously cleared femoral heads and acetabular components. The hip system is intended for cementless implantation. The hip stems are made of Ti-6AI-4V (ASTM F136) with a commercially pure titanium plasma spray coating (ASTM F1580) and the modular necks are made of CoCr alloy (ASTM F1537).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip joint
Indicated Patient Age Range
skeletally mature individuals
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The non-clinical tests performed by the company include neck endurance, stem fatigue, interconnection strength of modular connections, and ROM testing. The test results demonstrate that the MSA Hip System is substantially equivalent to legally marketed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K071916, K080584, K030733, K943230, K081090, K091423, K090845
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
510(k) Summary
MAR - 1 2011 Manufacturer: Global Manufacturing Technology 8-10 Resolution Drive Unanderra NSW 2526 AUSTRALIA Phone: (011) 61 (2) 4272 4493 Device Trade Name: MSA Hip System Contact: Mr. Ricardo Lucchini Director Of Regulatory Affairs Prepared By: Musculoskeletal Clinical Regulatory Advisers, LLC 1331 H Street, NW. 12th Floor Washington, DC 20005 Phone: (202) 552-5800 Fax: (202) 552-5798 Date Prepared: February 10, 2011 Classification: 21 CFR 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Class II MEH Product Codes: The MSA Hip System is indicated for cementless use and is Indications For Use: intended to replace a hip joint. The device is intended for: skeletally mature individuals undergoing primary � surgery for total hip replacement patients suffering from severe hip pain and disability . due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fracture of the femur. patients with congenital hip dysplasia, protrusio . acetabuli, or slipped capital femoral epiphysis patients suffering from disability due to previous fusion . patients with acute femoral neck fractures ●
1
Device Description: The MSA Hip System is a modular hip system consisting of a short stem which mates with a modular neck. The proximal portion of the stem has a plasma spray coating and a hydroxyapatite coating. The MSA Hip System can be mated with a number of previously cleared femoral heads and acetabular components. The hip system is intended for cementless implantation.
The hip stems are made of Ti-6AI-4V (ASTM F136) with a commercially pure titanium plasma spray coating (ASTM F1580) and the modular necks are made of CoCr alloy (ASTM F1537).
Comparative information presented in the 510(k) supports the substantial equivalence of the MSA Hip System with respect to its indications for use, design, materials, and This 510(k) demonstrates the method of fixation. substantial equivalence of the MSA Hip System to the following predicate devices: Aesculap Implant System's Metha Short Stem Hip System (K071916 and K080584); Zimmer's Mayo Conservative Hip Prosthesis (K030733 K943230): Wright Technology's and PROFEMUR Hip System (K081090 and K091423); and OMNI life science. Inc.'s Apex ARCTM Hip System (K090845).
The MSA Hip Stem shares the same indications for use for which the predicate systems were cleared. The geometry and design of the subject hip stem matches that of the predicate hips. The materials of the stem and neck are the same and the predicate stems and necks. Like the MSA Hip, the majority of the predicate stems are intended for cementless fixation.
The non-clinical tests performed by the company include Performance Data: neck endurance, stem fatigue, interconnection strength of modular connections, and ROM testing. The test results demonstrate that the MSA Hip System is substantially equivalent to legally marketed predicate devices.
Materials:
Predicate Devices:
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and wings. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Global Manufacturing Technology % Musculoskeltal Clinincal Regulatory Advisers, LLC Hollace S. Rhodes Director, Orthopedic Regulatory Affairs 1331 H St NW, 12th Floor Washington DC, 20005
MAR - 1 2011
Re: K102172
Trade/Device Name: MSA Hip System Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class II Product Code: MEH Dated: February 24, 2011 Received: February 25, 2011
Dear Ms. Rhodes:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act that I Drinas intact a and regulations administered by other Federal agencies. You must
3
Page - 2 - Ms. Hollace S. Rhodes
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Aliz. B. R k
for
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use 4.
510(k) Number (if known): _KIO2172 (gg 1/1)
Device Name: MSA Hip System
The MSA Hip System is indicated for cementless use and is intended to replace a hip joint.
The device is intended for:
- . skeletally mature individuals undergoing primary surgery for total hip replacement
- patients suffering from severe hip pain and disability due to rheumatoid arthritis, . osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fracture of the femur.
- patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral . epiphysis
- patients suffering from disability due to previous fusion .
- . patients with acute femoral neck fractures
Prescription Use (Part 29 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use no (29 CFR 801 Subpart C)
Concurrence of CDRH, Office of Device Evaluation (ODE)
for M. Melbern
(Division/Sign-Off)
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K102172